Insta
US Approves Booster Shots Of Pfizer And Moderna COVID-19 vaccines For People With Compromised Immune Systems
Swarajya Staff
Aug 13, 2021, 11:05 AM | Updated 11:05 AM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
The United States (US)’s Food and Drug Administration (FDA) has authorised a booster shot of mRNA COVID-19 vaccines from Pfizer and Modern for people who have compromised immune systems, reports Economic Times.
This comes as Germany and Israel have also either approved or are planning to approve the third booster shot as the Delta variant of the coronavirus continues to spread worldwide.
It should be noted that Pfizer has said that the efficacy of the vaccine it developed with BioNTech drops over time, citing a study that showed 84 per cent effectiveness from a peak of 96 per cent four months after a second dose.
Meanwhile, Moderna has also said it sees the eventual need for booster doses, especially since the Delta variant has caused ‘breakthrough’ infections in fully vaccinated people.
It should be noted that the World Health Organization (WHO) had last week called for a moratorium on COVID-19 vaccine booster shots until at least the end of September.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.